![]() |
Form 4 Filings | Insider Buys | Significant Buys |
Penny Stocks Insider Buying |
Insider Sales |
Insider Buy Sell Ratios | Stock Options |
Insider Trading Stock Screener |
Insider Trading Graph View |
Insider Watch |
|
"Insiders might sell their shares for any number of reasons, but they buy them for only one:
they think the price will rise"
- Peter Lynch What is insider trading>> |
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2019-02-14 Sale |
2019-02-19 4:19 pm |
REGENXBIO Inc. | RGNX | Mills Kenneth T. CEO |
15,000 | $47.29 | $709,284 | 261,000 (Direct) |
View |
2019-02-05 Sale |
2019-02-07 4:18 pm |
REGENXBIO Inc. | RGNX | Simpson Curran CTO |
43,832 | $50.08 | $2,195,107 | 83,332 (Direct) |
View |
2019-01-15 Sale |
2019-01-17 4:18 pm |
REGENXBIO Inc. | RGNX | Mills Kenneth T. CEO |
15,000 | $43.85 | $657,698 | 204,140 (Direct) |
View |
2018-12-18 Sale |
2018-12-20 4:27 pm |
REGENXBIO Inc. | RGNX | Christmas Patrick J. VP |
5,000 | $47.54 | $237,698 | 53,472 (Direct) |
View |
2018-12-17 Sale |
2018-12-19 4:32 pm |
REGENXBIO Inc. | RGNX | Vasista Vittal CFO |
7,500 | $46.35 | $347,650 | 125,683 (Direct) |
View |
2018-12-17 Sale |
2018-12-19 4:20 pm |
REGENXBIO Inc. | RGNX | Mills Kenneth T. CEO |
15,000 | $46.73 | $700,927 | 223,396 (Direct) |
View |
2018-12-03 Sale |
2018-12-06 4:22 pm |
REGENXBIO Inc. | RGNX | Yoo Stephen Chief Medical Officer |
20,414 | $60.13 | $1,227,412 | 40,830 (Direct) |
View |
2018-12-03 Sale |
2018-12-06 4:19 pm |
REGENXBIO Inc. | RGNX | Mills Kenneth T. CEO |
20,000 | $60.4 | $1,208,087 | 232,300 (Direct) |
View |
2018-11-29 Sale |
2018-12-03 4:19 pm |
REGENXBIO Inc. | RGNX | BESHAR LUKE M Director |
12,784 | $65 | $830,960 | 53,000 (Direct) |
View |
2018-11-26 Sale |
2018-11-28 4:20 pm |
REGENXBIO Inc. | RGNX | BESHAR LUKE M Director |
20,507 | $65.03 | $1,333,519 | 65,784 (Direct) |
View |
2018-11-26 Sale |
2018-11-28 4:18 pm |
REGENXBIO Inc. | RGNX | Mills Kenneth T. CEO |
20,000 | $64.17 | $1,283,355 | 259,620 (Direct) |
View |
2018-11-21 Sale |
2018-11-26 4:17 pm |
REGENXBIO Inc. | RGNX | Mills Kenneth T. CEO |
15,000 | $61.44 | $921,660 | 284,700 (Direct) |
View |
2018-11-19 Sale |
2018-11-21 4:26 pm |
REGENXBIO Inc. | RGNX | BESHAR LUKE M Director |
33,292 | $60.44 | $2,012,209 | 66,500 (Direct) |
View |
2018-11-19 Sale |
2018-11-21 4:21 pm |
REGENXBIO Inc. | RGNX | Yoo Stephen Chief Medical Officer |
20,414 | $59.53 | $1,215,344 | 61,244 (Direct) |
View |
2018-11-16 Sale |
2018-11-20 4:19 pm |
REGENXBIO Inc. | RGNX | Simpson Curran VP |
32,882 | $63.76 | $2,096,418 | 76,101 (Direct) |
View |
2018-11-15 Sale |
2018-11-19 4:16 pm |
REGENXBIO Inc. | RGNX | Vasista Vittal CFO |
7,500 | $60.29 | $452,206 | 135,113 (Direct) |
View |
2018-11-12 Sale |
2018-11-14 4:20 pm |
REGENXBIO Inc. | RGNX | Mills Kenneth T. CEO |
20,000 | $63.11 | $1,262,261 | 292,414 (Direct) |
View |
2018-11-07 Sale |
2018-11-09 4:20 pm |
REGENXBIO Inc. | RGNX | Christmas Patrick J. VP |
15,000 | $72.06 | $1,080,900 | 2,669 (Direct) |
View |
2018-11-05 Sale |
2018-11-07 6:02 pm |
REGENXBIO Inc. | RGNX | Yoo Stephen Chief Medical Officer |
20,414 | $68.28 | $1,393,933 | 81,658 (Direct) |
View |
2018-11-05 Sale |
2018-11-07 6:00 pm |
REGENXBIO Inc. | RGNX | Mills Kenneth T. CEO |
20,000 | $68.25 | $1,364,902 | 322,500 (Direct) |
View |
2018-11-01 Sale |
2018-11-05 4:20 pm |
REGENXBIO Inc. | RGNX | Vasista Vittal CFO |
73,418 | $70.2 | $5,154,020 | 191,024 (Direct) |
View |
2018-10-29 Sale |
2018-10-31 4:22 pm |
REGENXBIO Inc. | RGNX | Yoo Stephen Chief Medical Officer |
20,414 | $62.37 | $1,273,212 | 102,072 (Direct) |
View |
2018-10-18 Sale |
2018-10-22 4:16 pm |
REGENXBIO Inc. | RGNX | Christmas Patrick J. VP |
5,000 | $61.78 | $308,890 | 58,472 (Direct) |
View |
2018-10-16 Sale |
2018-10-18 4:24 pm |
REGENXBIO Inc. | RGNX | Simpson Curran VP |
62,309 | $60.85 | $3,791,503 | 108,983 (Direct) |
View |
2018-10-15 Sale |
2018-10-17 4:29 pm |
REGENXBIO Inc. | RGNX | Yoo Stephen Chief Medical Officer |
20,414 | $60.28 | $1,230,541 | 132,900 (Direct) |
View |
2018-10-15 Sale |
2018-10-17 4:24 pm |
REGENXBIO Inc. | RGNX | Vasista Vittal CFO |
7,500 | $59.37 | $445,275 | 142,283 (Direct) |
View |
2018-10-15 Sale |
2018-10-17 4:17 pm |
REGENXBIO Inc. | RGNX | Mills Kenneth T. CEO |
7,510 | $59.35 | $445,744 | 331,710 (Direct) |
View |
2018-10-08 Sale |
2018-10-10 4:20 pm |
REGENXBIO Inc. | RGNX | Danos Olivier Chief Scientific Officer |
20,000 | $63.8 | $1,275,914 | 80,000 (Direct) |
View |
2018-09-17 Sale |
2018-09-19 4:26 pm |
REGENXBIO Inc. | RGNX | Vasista Vittal CFO |
7,500 | $74.86 | $561,472 | 204,900 (Direct) |
View |
2018-09-17 Sale |
2018-09-19 4:24 pm |
REGENXBIO Inc. | RGNX | Mills Kenneth T. CEO |
7,510 | $74.91 | $562,564 | 339,505 (Direct) |
View |
2018-08-27 Sale |
2018-08-29 4:20 pm |
REGENXBIO Inc. | RGNX | Mills Kenneth T. CEO |
7,510 | $66.46 | $499,118 | 348,530 (Direct) |
View |
2018-08-20 Sale |
2018-08-22 4:15 pm |
REGENXBIO Inc. | RGNX | Christmas Patrick J. VP |
5,000 | $65.96 | $329,806 | 63,472 (Direct) |
View |
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2019-02-14 Exercise |
2019-02-19 4:19 pm |
N/A N/A |
REGENXBIO Inc. | RGNX | Mills Kenneth T. CEO |
15,000 | $0.85 | 261,000 (Direct) |
View |
2019-02-14 Exercise |
2019-02-19 4:19 pm |
N/A 2024-09-23 |
REGENXBIO Inc. | RGNX | Mills Kenneth T. CEO |
15,000 | $0.85 | 261,000 (Direct) |
View |
2019-02-07 Exercise |
2019-02-11 4:20 pm |
N/A N/A |
REGENXBIO Inc. | RGNX | Vasista Vittal CFO |
120,000 | $0.85 | 242,283 (Direct) |
View |
2019-02-07 Exercise |
2019-02-11 4:20 pm |
N/A 2024-09-23 |
REGENXBIO Inc. | RGNX | Vasista Vittal CFO |
120,000 | $0.85 | 242,283 (Direct) |
View |
2019-02-05 Exercise |
2019-02-07 4:18 pm |
N/A N/A |
REGENXBIO Inc. | RGNX | Simpson Curran CTO |
8,450 | $35.8 | 83,332 (Direct) |
View |
2019-02-05 Exercise |
2019-02-07 4:18 pm |
N/A N/A |
REGENXBIO Inc. | RGNX | Simpson Curran CTO |
32,882 | $22 | 83,332 (Direct) |
View |
2019-02-05 Exercise |
2019-02-07 4:18 pm |
N/A N/A |
REGENXBIO Inc. | RGNX | Simpson Curran CTO |
1,875 | $19.5 | 83,332 (Direct) |
View |
2019-02-05 Exercise |
2019-02-07 4:18 pm |
N/A N/A |
REGENXBIO Inc. | RGNX | Simpson Curran CTO |
625 | $13.09 | 83,332 (Direct) |
View |
2019-02-05 Exercise |
2019-02-07 4:18 pm |
N/A 2028-01-03 |
REGENXBIO Inc. | RGNX | Simpson Curran CTO |
8,450 | $35.8 | 83,332 (Direct) |
View |
2019-02-05 Exercise |
2019-02-07 4:18 pm |
N/A 2025-08-30 |
REGENXBIO Inc. | RGNX | Simpson Curran CTO |
32,882 | $22 | 83,332 (Direct) |
View |
2019-02-05 Exercise |
2019-02-07 4:18 pm |
N/A 2027-01-03 |
REGENXBIO Inc. | RGNX | Simpson Curran CTO |
1,875 | $19.5 | 83,332 (Direct) |
View |
2019-02-05 Exercise |
2019-02-07 4:18 pm |
N/A 2026-01-27 |
REGENXBIO Inc. | RGNX | Simpson Curran CTO |
625 | $13.09 | 83,332 (Direct) |
View |
2019-02-01 Exercise |
2019-02-05 4:21 pm |
N/A N/A |
REGENXBIO Inc. | RGNX | Mills Kenneth T. CEO |
45,000 | $0.85 | 246,000 (Direct) |
View |
2019-02-01 Exercise |
2019-02-05 4:21 pm |
N/A 2024-09-23 |
REGENXBIO Inc. | RGNX | Mills Kenneth T. CEO |
45,000 | $0.85 | 246,000 (Direct) |
View |
2018-12-31 Option Award |
2019-01-07 4:27 pm |
N/A N/A |
REGENXBIO Inc. | RGNX | Christmas Patrick J. VP |
337 | $35.66 | 45,000 (Direct) |
View |
2018-12-31 Option Award |
2019-01-07 4:27 pm |
N/A 2029-01-03 |
REGENXBIO Inc. | RGNX | Christmas Patrick J. VP |
45,000 | $40.82 | 45,000 (Direct) |
View |
2019-01-03 Option Award |
2019-01-07 4:25 pm |
N/A 2029-01-03 |
REGENXBIO Inc. | RGNX | Simpson Curran CTO |
46,000 | $40.82 | 46,000 (Direct) |
View |
2019-01-03 Option Award |
2019-01-07 4:24 pm |
N/A 2029-01-03 |
REGENXBIO Inc. | RGNX | Danos Olivier Chief Scientific Officer |
48,000 | $40.82 | 48,000 (Direct) |
View |
2019-01-03 Option Award |
2019-01-07 4:23 pm |
N/A 2029-01-03 |
REGENXBIO Inc. | RGNX | Vasista Vittal CFO |
57,000 | $40.82 | 57,000 (Direct) |
View |
2019-01-03 Option Award |
2019-01-07 4:20 pm |
N/A 2029-01-03 |
REGENXBIO Inc. | RGNX | Mills Kenneth T. CEO |
190,000 | $40.82 | 190,000 (Direct) |
View |
2018-12-18 Exercise |
2018-12-20 4:27 pm |
N/A N/A |
REGENXBIO Inc. | RGNX | Christmas Patrick J. VP |
5,000 | $12.1 | 53,472 (Direct) |
View |
2018-12-18 Exercise |
2018-12-20 4:27 pm |
N/A 2026-08-17 |
REGENXBIO Inc. | RGNX | Christmas Patrick J. VP |
5,000 | $12.1 | 53,472 (Direct) |
View |
2018-12-03 Exercise |
2018-12-06 4:22 pm |
N/A N/A |
REGENXBIO Inc. | RGNX | Yoo Stephen Chief Medical Officer |
20,414 | $0.85 | 40,830 (Direct) |
View |
2018-12-03 Exercise |
2018-12-06 4:22 pm |
N/A 2024-11-03 |
REGENXBIO Inc. | RGNX | Yoo Stephen Chief Medical Officer |
20,414 | $0.85 | 40,830 (Direct) |
View |
2018-11-30 Exercise |
2018-12-04 4:19 pm |
N/A N/A |
REGENXBIO Inc. | RGNX | Danos Olivier Chief Scientific Officer |
1,500 | $20.35 | 78,500 (Direct) |
View |
2018-11-30 Exercise |
2018-12-04 4:19 pm |
N/A 2027-03-26 |
REGENXBIO Inc. | RGNX | Danos Olivier Chief Scientific Officer |
1,500 | $20.35 | 78,500 (Direct) |
View |
2018-11-29 Exercise |
2018-12-03 4:19 pm |
N/A N/A |
REGENXBIO Inc. | RGNX | BESHAR LUKE M Director |
12,784 | $3.76 | 53,000 (Direct) |
View |
2018-11-29 Exercise |
2018-12-03 4:19 pm |
N/A 2025-05-18 |
REGENXBIO Inc. | RGNX | BESHAR LUKE M Director |
12,784 | $3.76 | 53,000 (Direct) |
View |
2018-11-26 Exercise |
2018-11-28 4:20 pm |
N/A N/A |
REGENXBIO Inc. | RGNX | BESHAR LUKE M Director |
1,721 | $49.45 | 65,784 (Direct) |
View |
2018-11-26 Exercise |
2018-11-28 4:20 pm |
N/A N/A |
REGENXBIO Inc. | RGNX | BESHAR LUKE M Director |
883 | $49.45 | 65,784 (Direct) |
View |
2018-11-26 Exercise |
2018-11-28 4:20 pm |
N/A N/A |
REGENXBIO Inc. | RGNX | BESHAR LUKE M Director |
4,687 | $22 | 65,784 (Direct) |
View |
2018-11-26 Exercise |
2018-11-28 4:20 pm |
N/A N/A |
REGENXBIO Inc. | RGNX | BESHAR LUKE M Director |
6,250 | $18.85 | 65,784 (Direct) |
View |
2018-11-26 Exercise |
2018-11-28 4:20 pm |
N/A N/A |
REGENXBIO Inc. | RGNX | BESHAR LUKE M Director |
6,250 | $12.74 | 65,784 (Direct) |
View |
2018-11-26 Exercise |
2018-11-28 4:20 pm |
N/A N/A |
REGENXBIO Inc. | RGNX | BESHAR LUKE M Director |
716 | $3.76 | 65,784 (Direct) |
View |
2018-11-26 Exercise |
2018-11-28 4:20 pm |
N/A 2028-05-25 |
REGENXBIO Inc. | RGNX | BESHAR LUKE M Director |
1,721 | $49.45 | 65,784 (Direct) |
View |
2018-11-26 Exercise |
2018-11-28 4:20 pm |
N/A 2028-05-25 |
REGENXBIO Inc. | RGNX | BESHAR LUKE M Director |
883 | $49.45 | 65,784 (Direct) |
View |
2018-11-26 Exercise |
2018-11-28 4:20 pm |
N/A 2025-09-16 |
REGENXBIO Inc. | RGNX | BESHAR LUKE M Director |
4,687 | $22 | 65,784 (Direct) |
View |
2018-11-26 Exercise |
2018-11-28 4:20 pm |
N/A 2027-05-24 |
REGENXBIO Inc. | RGNX | BESHAR LUKE M Director |
6,250 | $18.85 | 65,784 (Direct) |
View |
2018-11-26 Exercise |
2018-11-28 4:20 pm |
N/A 2026-06-01 |
REGENXBIO Inc. | RGNX | BESHAR LUKE M Director |
6,250 | $12.74 | 65,784 (Direct) |
View |
2018-11-26 Exercise |
2018-11-28 4:20 pm |
N/A 2025-05-18 |
REGENXBIO Inc. | RGNX | BESHAR LUKE M Director |
716 | $3.76 | 65,784 (Direct) |
View |
2018-11-19 Exercise |
2018-11-21 4:26 pm |
N/A N/A |
REGENXBIO Inc. | RGNX | BESHAR LUKE M Director |
2,604 | $49.45 | 66,500 (Direct) |
View |
2018-11-19 Exercise |
2018-11-21 4:26 pm |
N/A N/A |
REGENXBIO Inc. | RGNX | BESHAR LUKE M Director |
6,250 | $18.85 | 66,500 (Direct) |
View |
2018-11-19 Exercise |
2018-11-21 4:26 pm |
N/A N/A |
REGENXBIO Inc. | RGNX | BESHAR LUKE M Director |
3,262 | $12.74 | 66,500 (Direct) |
View |
2018-11-19 Exercise |
2018-11-21 4:26 pm |
N/A N/A |
REGENXBIO Inc. | RGNX | BESHAR LUKE M Director |
4,688 | $22 | 66,500 (Direct) |
View |
2018-11-19 Exercise |
2018-11-21 4:26 pm |
N/A N/A |
REGENXBIO Inc. | RGNX | BESHAR LUKE M Director |
2,988 | $12.74 | 66,500 (Direct) |
View |
2018-11-19 Exercise |
2018-11-21 4:26 pm |
N/A N/A |
REGENXBIO Inc. | RGNX | BESHAR LUKE M Director |
13,500 | $3.76 | 66,500 (Direct) |
View |
2018-11-19 Exercise |
2018-11-21 4:26 pm |
N/A 2028-05-25 |
REGENXBIO Inc. | RGNX | BESHAR LUKE M Director |
2,604 | $49.45 | 66,500 (Direct) |
View |
2018-11-19 Exercise |
2018-11-21 4:26 pm |
N/A 2027-05-24 |
REGENXBIO Inc. | RGNX | BESHAR LUKE M Director |
6,250 | $18.85 | 66,500 (Direct) |
View |
2018-11-19 Exercise |
2018-11-21 4:26 pm |
N/A 2026-06-01 |
REGENXBIO Inc. | RGNX | BESHAR LUKE M Director |
3,262 | $12.74 | 66,500 (Direct) |
View |
2018-11-19 Exercise |
2018-11-21 4:26 pm |
N/A 2025-09-16 |
REGENXBIO Inc. | RGNX | BESHAR LUKE M Director |
4,688 | $22 | 66,500 (Direct) |
View |
2018-11-19 Exercise |
2018-11-21 4:26 pm |
N/A 2026-06-01 |
REGENXBIO Inc. | RGNX | BESHAR LUKE M Director |
2,988 | $12.74 | 66,500 (Direct) |
View |
2018-11-19 Exercise |
2018-11-21 4:26 pm |
N/A 2025-05-18 |
REGENXBIO Inc. | RGNX | BESHAR LUKE M Director |
13,500 | $3.76 | 66,500 (Direct) |
View |
2018-11-19 Exercise |
2018-11-21 4:21 pm |
N/A N/A |
REGENXBIO Inc. | RGNX | Yoo Stephen Chief Medical Officer |
20,414 | $0.85 | 61,244 (Direct) |
View |
2018-11-19 Exercise |
2018-11-21 4:21 pm |
N/A 2024-11-03 |
REGENXBIO Inc. | RGNX | Yoo Stephen Chief Medical Officer |
20,414 | $0.85 | 61,244 (Direct) |
View |
2018-11-16 Exercise |
2018-11-20 4:19 pm |
N/A N/A |
REGENXBIO Inc. | RGNX | Simpson Curran VP |
32,882 | $22 | 76,101 (Direct) |
View |
2018-11-16 Exercise |
2018-11-20 4:19 pm |
N/A 2025-08-30 |
REGENXBIO Inc. | RGNX | Simpson Curran VP |
32,882 | $22 | 76,101 (Direct) |
View |
2018-11-05 Exercise |
2018-11-07 6:02 pm |
N/A N/A |
REGENXBIO Inc. | RGNX | Yoo Stephen Chief Medical Officer |
20,414 | $0.85 | 81,658 (Direct) |
View |
2018-11-05 Exercise |
2018-11-07 6:02 pm |
N/A 2024-11-03 |
REGENXBIO Inc. | RGNX | Yoo Stephen Chief Medical Officer |
20,414 | $0.85 | 81,658 (Direct) |
View |
2018-11-01 Exercise |
2018-11-05 4:20 pm |
N/A N/A |
REGENXBIO Inc. | RGNX | Vasista Vittal CFO |
9,959 | $3.76 | 191,024 (Direct) |
View |
2018-11-01 Exercise |
2018-11-05 4:20 pm |
N/A N/A |
REGENXBIO Inc. | RGNX | Vasista Vittal CFO |
9,718 | $13.09 | 191,024 (Direct) |
View |
2018-11-01 Exercise |
2018-11-05 4:20 pm |
N/A N/A |
REGENXBIO Inc. | RGNX | Vasista Vittal CFO |
32,908 | $13.09 | 191,024 (Direct) |
View |
2018-11-01 Exercise |
2018-11-05 4:20 pm |
N/A N/A |
REGENXBIO Inc. | RGNX | Vasista Vittal CFO |
20,833 | $19.5 | 191,024 (Direct) |
View |
2018-11-01 Exercise |
2018-11-05 4:20 pm |
N/A 2025-05-18 |
REGENXBIO Inc. | RGNX | Vasista Vittal CFO |
9,959 | $3.76 | 191,024 (Direct) |
View |
2018-11-01 Exercise |
2018-11-05 4:20 pm |
N/A 2026-01-27 |
REGENXBIO Inc. | RGNX | Vasista Vittal CFO |
9,718 | $13.09 | 191,024 (Direct) |
View |
2018-11-01 Exercise |
2018-11-05 4:20 pm |
N/A 2026-01-27 |
REGENXBIO Inc. | RGNX | Vasista Vittal CFO |
32,908 | $13.09 | 191,024 (Direct) |
View |
2018-11-01 Exercise |
2018-11-05 4:20 pm |
N/A 2027-01-03 |
REGENXBIO Inc. | RGNX | Vasista Vittal CFO |
20,833 | $19.5 | 191,024 (Direct) |
View |
2018-10-29 Exercise |
2018-10-31 4:22 pm |
N/A N/A |
REGENXBIO Inc. | RGNX | Yoo Stephen Chief Medical Officer |
20,414 | $0.85 | 102,072 (Direct) |
View |
2018-10-29 Exercise |
2018-10-31 4:22 pm |
N/A 2024-11-03 |
REGENXBIO Inc. | RGNX | Yoo Stephen Chief Medical Officer |
20,414 | $0.85 | 102,072 (Direct) |
View |
2018-10-18 Exercise |
2018-10-22 4:16 pm |
N/A N/A |
REGENXBIO Inc. | RGNX | Christmas Patrick J. VP |
5,000 | $12.1 | 58,472 (Direct) |
View |
2018-10-18 Exercise |
2018-10-22 4:16 pm |
N/A 2026-08-17 |
REGENXBIO Inc. | RGNX | Christmas Patrick J. VP |
5,000 | $12.1 | 58,472 (Direct) |
View |
2018-10-16 Exercise |
2018-10-18 4:24 pm |
N/A N/A |
REGENXBIO Inc. | RGNX | Simpson Curran VP |
46,517 | $22 | 108,983 (Direct) |
View |
2018-10-16 Exercise |
2018-10-18 4:24 pm |
N/A N/A |
REGENXBIO Inc. | RGNX | Simpson Curran VP |
13,125 | $19.5 | 108,983 (Direct) |
View |
2018-10-16 Exercise |
2018-10-18 4:24 pm |
N/A N/A |
REGENXBIO Inc. | RGNX | Simpson Curran VP |
2,667 | $13.09 | 108,983 (Direct) |
View |
2018-10-16 Exercise |
2018-10-18 4:24 pm |
N/A 2025-08-30 |
REGENXBIO Inc. | RGNX | Simpson Curran VP |
46,517 | $22 | 108,983 (Direct) |
View |
2018-10-16 Exercise |
2018-10-18 4:24 pm |
N/A 2027-01-03 |
REGENXBIO Inc. | RGNX | Simpson Curran VP |
13,125 | $19.5 | 108,983 (Direct) |
View |
2018-10-16 Exercise |
2018-10-18 4:24 pm |
N/A 2026-01-27 |
REGENXBIO Inc. | RGNX | Simpson Curran VP |
2,667 | $13.09 | 108,983 (Direct) |
View |
2018-10-15 Exercise |
2018-10-17 4:29 pm |
N/A N/A |
REGENXBIO Inc. | RGNX | Yoo Stephen Chief Medical Officer |
10,000 | $0.85 | 132,900 (Direct) |
View |
2018-10-15 Exercise |
2018-10-17 4:29 pm |
N/A N/A |
REGENXBIO Inc. | RGNX | Yoo Stephen Chief Medical Officer |
10,414 | $0.85 | 132,900 (Direct) |
View |
2018-10-15 Exercise |
2018-10-17 4:29 pm |
N/A 2024-11-03 |
REGENXBIO Inc. | RGNX | Yoo Stephen Chief Medical Officer |
10,000 | $0.85 | 132,900 (Direct) |
View |
2018-10-15 Exercise |
2018-10-17 4:29 pm |
N/A 2024-11-03 |
REGENXBIO Inc. | RGNX | Yoo Stephen Chief Medical Officer |
10,414 | $0.85 | 132,900 (Direct) |
View |
2018-10-08 Exercise |
2018-10-10 4:20 pm |
N/A N/A |
REGENXBIO Inc. | RGNX | Danos Olivier Chief Scientific Officer |
20,000 | $20.35 | 80,000 (Direct) |
View |
2018-10-08 Exercise |
2018-10-10 4:20 pm |
N/A 2027-03-26 |
REGENXBIO Inc. | RGNX | Danos Olivier Chief Scientific Officer |
20,000 | $20.35 | 80,000 (Direct) |
View |
2018-09-17 Exercise |
2018-09-19 4:26 pm |
N/A N/A |
REGENXBIO Inc. | RGNX | Vasista Vittal CFO |
30,000 | $0.85 | 204,900 (Direct) |
View |
2018-09-17 Exercise |
2018-09-19 4:26 pm |
N/A 2024-09-23 |
REGENXBIO Inc. | RGNX | Vasista Vittal CFO |
30,000 | $0.85 | 204,900 (Direct) |
View |
2018-08-27 Exercise |
2018-08-29 4:20 pm |
N/A N/A |
REGENXBIO Inc. | RGNX | Mills Kenneth T. CEO |
145,000 | $0.85 | 348,530 (Direct) |
View |
2018-08-27 Exercise |
2018-08-29 4:20 pm |
N/A 2024-09-23 |
REGENXBIO Inc. | RGNX | Mills Kenneth T. CEO |
145,000 | $0.85 | 348,530 (Direct) |
View |
2018-08-20 Exercise |
2018-08-22 4:15 pm |
N/A N/A |
REGENXBIO Inc. | RGNX | Christmas Patrick J. VP |
5,000 | $12.1 | 63,472 (Direct) |
View |
2018-08-20 Exercise |
2018-08-22 4:15 pm |
N/A 2026-08-17 |
REGENXBIO Inc. | RGNX | Christmas Patrick J. VP |
5,000 | $12.1 | 63,472 (Direct) |
View |
© 2005-2019 SecForm4.Com All rights reserved. Archives: 2019 2018 2017 2016 2015 2014 ... Thu, 21 Feb 2019 05:59:59 -0600 |
SEC is the U.S. Securities and Exchange Commission. EDGAR is a trademark of the SEC.
SecForm4.Com is not affiliated with or approved by the U.S. Securities and Exchange Commission (SEC). Terms of Use | Privacy Statement | |